The second most common cancer among men is prostate cancer, affecting 1 in 8 men. Prostate cancer is treatable, in most cases, when the cancer remains localized to the prostate gland. But if the ...

Bone metastases are cancers that have spread (metastasized) from other tissues in the body through the blood or lymphatic systems to the bone marrow. Bone metastases form the main type of bone ...

Metastatic breast cancer is complex, requiring holistic care and ongoing treatment, with varying prognosis depending on several factors.

More people have colon cancer spread to their bones than in years past. This may be because colon cancer treatments have improved, which allows people to live longer, giving the cancer more time ...

During a live event, Payal D. Shah, MD, discusses the case of a woman with metastatic breast cancer and the data for ...

researchers looked at the survival rates for lung cancer that had spread to the bones. They found that the median survival time following diagnosis was about 148 days. Survival rates are ...

Doctors use it if the tumors are only in a small part of the lung (they’ll call this isolated or limited metastasis). It can also help when the primary cancer is colorectal cancer, bone cancer ...

Obesity is associated with an increased risk of developing breast cancer, and a greater probability for the cancer to spread to other organs – metastasize –. But the causes of this association are ...

A new drug that works against the main types of primary bone cancer has been developed by researchers at the University of East Anglia and University of Sheffield. Cancer that starts in the bones ...

This section is about radiotherapy for cancer that starts in your bone (primary bone cancer). If your cancer has spread into bone from another part of the body, it is called secondary bone cancer.

Cancer that is confined to its original location is easiest to treat, but cancer cells can break off and spread to other parts of the body. Scientists studying how cancers spread have found that ...

Radiographic disappearance of metastases could be a surrogate marker for outcomes among patients treated for metastatic ...